Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Morgan Stanley

Morgan Stanley Insight Fund Class IR (MBIRX)

Ticker MBIRX · · Holdings as of Jun 30, 2026

Expense ratio
0.85%$85/yr per $10k
5-yr return
−0.5%annualized
1-yr return
+19.3%as of Dec 2025
Net assets
$1.2Ball share classes
Holdings
46

Bottom line

Is MBIRX a good fund? The bottom line

MBIRX is the Class IR share class of Morgan Stanley Insight Fund, a managed large blend mutual fund from Morgan Stanley.

Its expense ratio is 0.85% — about $85 a year on every $10,000 invested, more expensive than 52% of large blend funds we track.

It returned +19.3% over one year, −0.5% a year over five years (as of Dec 31, 2025, per its prospectus).

With $1.2 billion in net assets and 46 holdings, its largest position is Cloudflare Inc (13.2%) and the top 10 make up 65% of the portfolio.

What to watch

  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 65% of assets

Updated Nov 19, 2026

What MBIRX invests in

Morgan Stanley Insight Fund (the Fund) seeks long-term capital appreciation.

Under normal circumstances, the Funds assets will be invested primarily in a portfolio of common stocks of companies with market capitalizations, at the time of purchase, within the capitalization range of the companies comprising the Russell 3000 Growth Index, which as of December 31, ? 2025 was between $ 13.7 million and $ 4.5 trillion. The Adviser seeks long-term capital appreciation by investing primarily in established and emerging companies. The Adviser emphasizes a bottom-up stock selection process, seeking attractive investments on an individual company basis. In selecting securities for investment, the Adviser typically invests in unique companies it believes have sustainable competitive advantages with above average business visibility, the ability to deploy capital at high rates of return, strong balance sheets and an attractive risk/reward. The Fund may invest in other…

From the fund's prospectus (filed Apr 30, 2026).

MBIRX performance

Fund calendar-year total returns, 2020–2025 2020: +116.8%; 2021: −6.2%; 2022: −61.3%; 2023: +53.2%; 2024: +46.8%; 2025: +19.3% +116.8% 2020 −6.2% 2021 −61.3% 2022 +53.2% 2023 +46.8% 2024 +19.3% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MBIRX+19.3%−0.5%—
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full MBIRX performance history →

What MBIRX costs

On a $10,000 investment, MBIRX's 0.85% expense ratio costs about $85 a year. The prospectus estimates $8,333 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full MBIRX fee table →

MBIRX top 10 holdings

#Holding% of fund
1Cloudflare Inc13.23%
2Royalty Pharma PLC7.82%
3Tesla Inc7.64%
4Affirm Holdings Inc6.47%
5IonQ Inc5.70%
6AppLovin Corp5.07%
7Opendoor Technologies Inc4.89%
8Space Exploration Technologies Corp4.87%
9Aurora Innovation Inc4.73%
10Roivant Sciences Ltd4.59%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 65% of the fund. See all top 25 holdings and asset mix →

Alternatives to MBIRX

More funds like MBIRX →

MBIRX FAQ

What is the expense ratio of MBIRX?
MBIRX's expense ratio is 0.85%, which works out to about $85 a year for every $10,000 invested. The prospectus estimates total costs of $8,333 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MBIRX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 65% of assets. This is general information, not personalized advice.
What does MBIRX hold?
MBIRX's largest holdings are Cloudflare Inc (13.2%), Royalty Pharma PLC (7.8%), Tesla Inc (7.6%), Affirm Holdings Inc (6.5%), IonQ Inc (5.7%). It holds 46 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MBIRX's 5-year return?
MBIRX returned −0.5% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Who manages MBIRX?
MBIRX is offered by Morgan Stanley through Morgan Stanley Insight Fund.